Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Liang

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
BMC Infectious Diseases|January 20, 2025
A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortalityTuti P Merati, Evy Yunihastuti, Rudi Wisaksana, et al.
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Science Immunology|April 21, 2019
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccineKenta Matsuda, Jinghe Huang, Tongqing Zhou, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Annual trends and risk factors of late presentation of HIV at 19 referral hospitals in Indonesia: findings from the INA-PROACTIVE cohortDona Arlinda, Evy Yunihastuti, Agnes Rengga Indrati, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Science (New York, N.Y.)|December 14, 2023
HIV vaccines induce CD8<sup>+</sup> T cells with low antigen receptor sensitivityStephen A Migueles, Danielle M Nettere, Noah V Gavil, et al.
Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.
Science Translational Medicine|April 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adultsAlicia T Widge, Amelia R Hofstetter, Katherine V Houser, et al.
Pediatric Research|December 18, 2024
Pediatric SARS-CoV-2 long term outcomes study (PECOS): cross sectional analysis at baselineGina A Montealegre Sanchez, Lauren E Arrigoni, Alexandra B Yonts, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
BMC Infectious Diseases|January 20, 2025
A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortalityTuti P Merati, Evy Yunihastuti, Rudi Wisaksana, et al.
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Science Immunology|April 21, 2019
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccineKenta Matsuda, Jinghe Huang, Tongqing Zhou, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Annual trends and risk factors of late presentation of HIV at 19 referral hospitals in Indonesia: findings from the INA-PROACTIVE cohortDona Arlinda, Evy Yunihastuti, Agnes Rengga Indrati, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Science (New York, N.Y.)|December 14, 2023
HIV vaccines induce CD8<sup>+</sup> T cells with low antigen receptor sensitivityStephen A Migueles, Danielle M Nettere, Noah V Gavil, et al.
Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.
Science Translational Medicine|April 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adultsAlicia T Widge, Amelia R Hofstetter, Katherine V Houser, et al.
Pediatric Research|December 18, 2024
Pediatric SARS-CoV-2 long term outcomes study (PECOS): cross sectional analysis at baselineGina A Montealegre Sanchez, Lauren E Arrigoni, Alexandra B Yonts, et al.
Pageof 8